BioAffinity Technologies Stock Skyrockets Wednesday: What's Happening?
bioAffinity Technologies is surging Wednesday as traders digest recent commercial expansion news alongside tight low-float trading dynamics.
Read original at benzingaStocks · News reference
bioAffinity Technologies shares are trading higher after the company announced that it is advancing the potential application of its CyPath Lung Test.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Dow Surges Over 200 Points; Ollie's Bargain Outlet Shares Gain After Q2 Earnings
U.S. stocks edged higher, led by the Dow and materials. Ollie’s beat EPS estimates; biotech and AI shares surged, while Tscan plunged 26%.
Read original at benzingaBioAffinity Advances Noninvasive CyPath Lung Test For Post-Treatment Monitoring
bioAffinity stock trades higher as it advances its CyPath Lung test for post-treatment lung cancer surveillance.
Read original at benzingaCrude Oil Surges 3%; ISM Manufacturing PMI Falls In August
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Tuesday.The Dow traded down 0.40% to 52,971.81 while the NASDAQ dipped 0.52% to 26,232.46. The S&P 500 also
Read original at benzinga